SCHEMBL9034857

SCHEMBL9034857

O=C1[N]c2ccccc2N(O)C1=O

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AADAT Q8N5Z0 6/20 0.36
GOT1 P17174 1/20 0.36
KYAT1 Q16773 1/20 0.36
KYAT3 Q6YP21 1/20 0.36
RNASEH1 O60930 1/20 0.32
KDR P35968 1/20 0.31
TLR9 Q9NR96 1/20 0.31
KDM4E B2RXH2 2/20 0.31
ALDH1A1 P00352 2/20 0.31
GAA P10253 1/20 0.31
CES1 P23141 4/20 0.31
TTR P02766 1/20 0.31
ERCC1 P07992 1/20 0.31
FEN1 P39748 1/20 0.31
ERCC4 Q92889 1/20 0.31
ALDH2 P05091 1/20 0.30
CHRM1 P11229 1/20 0.30
ALDH3A1 P30838 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8559311 0.76 TLR9 (0.31) TLR9ALDH1A1CES1TTR
SCHEMBL6013602 0.76 TTR (0.47) KDM4EALDH1A1CES1TTR
SCHEMBL2338193 0.73 ALDH1A1 (0.50) ALDH1A1GAACES1
SCHEMBL8555900 0.72 CA12 (0.50) KDM4EALDH1A1
SCHEMBL6013595 0.72 ALDH1A1 (0.46) KDM4EALDH1A1
SCHEMBL2228228 0.71 OPRL1 (0.40)
SCHEMBL8556011 0.69 MEN1 (0.32) KDM4EALDH1A1
SCHEMBL8087889 0.64 CES1 (0.57) ALDH1A1GAACES1TTRALDH2
SCHEMBL2354261 0.63 TTR (0.41) TLR9KDM4EALDH1A1CES1TTR
SCHEMBL7985252 0.62 TTR (0.53) ALDH1A1CES1TTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0743855-A1 8-AZA, 6-AZA AND 6,8-DIAZA-1,4-DIHYDROQUINOXALINE-2,3-DIONES AND THE USE THEREOF AS ANTAGONISTS FOR THE GLYCINE/NMDA RECEPTOR ACEA PHARMACEUTICALS, INC. (US) 1996-11-27 EP disclosed
WO-1995018616-A2 8-AZA, 6-AZA AND 6,8-DIAZA-1,4-DIHYDROQUINOXALINE-2,3-DIONES AND THE USE THEREOF AS ANTAGONISTS FOR THE GLYCINE/NMDA RECEPTOR ACEA PHARM INC (US) 1995-07-13 WO disclosed